Sorry!! The article you are trying to read is not available now.
Illumina (ILMN) drops as Roche deal apparently falls through
Normal 0 false false false MicrosoftInternetExplorer4 Illumina Inc. (NASDAQ: ILMN) fell back by 8.3% to $50.22 on Monday after Roche Holding AG Chairman Franz Humer said in an interview that the company does not plan to buy the gene sequencing specialist. Share volume was 3.7 million, more than doubling its daily average /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here